PhytoTech Medical Limited (ASX:PYL), is pleased to announce that it has completed the acquisition of 100% of the issued capital of MMJ Bioscience Inc. (MMJ). Shareholder approval was received on 29 June 2015 and all regulatory approvals have been satisfied to allow for the completion of the transaction.
Byte Power Group Limited (ASX:BPG) announced its earnings guidance for the 2014-15 financial year.
Leading big data solutions company Invigor Group Limited (ASX:IVO) ("Invigor") provides the following update on business performance and preliminary financial results.
PhytoTech Medical Ltd (ASX:PYL) are pleased to provide an investor presentation titled 'From Farm to Pharma - Unlocking the Medical Cannabis Value Chain'; a science-driven, global approach focused on the medicinal potential of Cannabis and its derivatives.
PhytoTech Medical Ltd (ASX:PYL) is pleased to announce that Satipharm AG ("Satipharm"), a 100% controlled entity of MMJ Bioscience Limited ("MMJ"), has signed an agreement with AI FAME GmbH ("AI FAME") to market and distribute its Medical Cannabis products globally.
Leading big data solutions company Invigor Group Limited (ASX:IVO) ("Invigor") has appointed widely renowned digital technology expert Gary Munitz as its Managing Director. Mr. Munitz will step up from his current role as Invigor's head of product development.
PhytoTech Medical Limited (ASX:PYL) (the "Company") is pleased to provide an update on the progress of its oral drug development. On the 11 June 2015 the Company submitted two formal clinical documents, which, when approved, will allow it to begin its Phase 1 study of its two pro-nano-lipospheres Tetrahyrocannabidiol (THC) and Cannabidiol (CBD) formulations.
